American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Beautywise which was recently featured on Shark Tank India is eyeing a revenue target of over Rs 1,200 crore by FY30.

The other important drugs like Prednisolone, Betamethasone and Dexamethasone are also expected to be commissioned this year.

Indian pharmaceutical CDMOs are anticipated to encounter minimal disruptions from the proposed US tariffs of 10-25 per cent.

The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...

Rakshit Chaurasiya, a law student implicated in the death of a woman and the injury of seven others in a car accident in ...